01. Gene therapy Boulikas.pdf - Gene therapy & Molecular Biology

Armentano D, Zabner J, Sacks C, Sookdeo CC, Smith MP, St
George JA, Wadsworth SC, Smith AE, Gregory RJ (1997)
Effect of the E4 region on the persistence of transgene
expression from adenovirus vectors. J Virol 71, 2408-2416.
Arteaga CL and Holt JT (1996) Tissue-targeted antisense c-fos
retroviral vector inhibits established breast cancer xenografts
in nude mice. Cancer Res 56, 1098-1103.
Arthur JF, Butterfield LH, Roth MD, Bui LA, Kiertscher SM,
Lau R, Dubinett S, Glaspy J, McBride WH, Economou JS
(1997) A comparison of gene transfer methods in human
dendritic cells. Cancer Gene Ther 4, 17-25.
Aruga E, Aruga A, Arca MJ, Lee WM, Yang NS, Smith JW 2nd,
Chang AE (1997) Immune responsiveness to a murine
mammary carcinoma modified to express B7-1, interleukin-
12, or GM-CSF. Cancer Gene Ther 4, 157-166.
Asahara T, Chen D, Tsurumi Y, Kearney M, Rossow S, Passeri
J, Symes JF, Isner JM (1996) Accelerated restitution of
endothelial integrity and endothelium-dependent function
after phVEGF165 gene transfer. Circulation 94, 3291-3302.
Austin EA and Huber BH (1993) A first step in the development
of gene therapy for colorectal carcinoma: Cloning,
sequencing, and expression of Escherichia coli cytosine
deaminase. Mol Pharmacol 43, 380-387.
Baasner S, von Melchner H, Klenner T, Hilgard P, Beckers T
(1996) Reversible tumorigenesis in mice by conditional
expression of the HER2/c-erbB2 receptor tyrosine kinase.
Oncogene 13, 901-911.
Bacchetti S and Graham FL (1993) Inhibition of cell
proliferation by an adenovirus vector expressing the human
wild-type p53 protein. Int J Oncol 3, 781-788.Baltimore D
(1988) Gene therapy. Intracellular immunization. Nature
335, 395-396.
Bagchi, S., Raychaudhuri, P. and Nevins, J.R. (1990) Adenovirus
E1A proteins can dissociate heteromeric complexes
involving the E2F transcription factor: a novel mechanism
for E1A trans-activation. Cell 62, 659-669.
Bagchi, S., Weinmann, R. and Raychaudhuri, P. (1991) The
retinoblastoma protein copurifies with E2F-I, and E1Aregulated
inhibitor of the transcription factor E2F. Cell 65,
1063-1072.
Baker SJ, Markowitz S, Fearon ER, Willson JKV, Vogelstein B
(1990) Suppression of human colorectal carcinoma cell
growth by wild-type p53. Science 249, 912-915.
Baldwin HS, Mickanin C, and Buck C (1997) Adenovirusmediated
gene transfer during initial organogenesis in the
mammalian embryo is promoter-dependent and tissuespecific.
Gene Ther 4, 1142-1149.
Balicki D and Beutler E (1997) Histone H2A significantly
enhances in vitro DNA transfection. Mol Med 3, 782-787.
Ballay A, Levrero M, Buendia MA, Tiollais P, Perricaudet M
(1985) In vitro and in vivo synthesis of the hepatitis B virus
surface antigen and of the receptor for polymerized human
serum albumin from recombinant human adenoviruses.
EMBO J 4, 3861-3865.
Bandara G, Mueller GM, Galea-Lauri J, Tindal MH, Georgescu
HI, Suchanek MK, Hung GL, Glorioso JC, Robbins PD,
Evans CH (1993) Intraarticular expression of biologically
Gene Therapy and Molecular Biology Vol 1, page 131
131
active interleukin 1-receptor-antagonist protein by ex vivo
gene transfer. Proc Natl Acad Sci USA 90, 10764-10768.
Banerjee S, Livanos E, Vos JM (1995) Therapeutic gene delivery
in human B-lymphoblastoid cells by engineered nontransforming
infectious Epstein-Barr virus. Nat Med 1,
1303-1308.
Barak Y, Juven T, Haffner R, Oren M (1993) mdm2 expression
is induced by wild typep53 activity. EMBO J 12: 461-468.
Bargonetti J, Friedman PN, Kern SE, Vogelstein B, Prives C
(1991) Wild-type but not mutant p53 immunopurified
proteins bind to sequences adjacent to the SV40 origin of
replication. Cell 65, 1083-1091.
Barr E, Leiden JM (1991) Systemic delivery of recombinant
proteins by genetically modified myoblasts. Science 254,
1507-1509.
Barry MA, Dower WJ, Johnston SA (1996) Toward celltargeting
gene therapy vectors: Selection of cell-binding
peptides from random peptide-presenting phage libraries.
Nature Med 2, 299-305.
Barton NW, Furbish FS, Murray GJ, Garfield M, Brady RO
(1990) Therapeutic response to intravenous infusions of
glucocerebrosidase in a patient with Gaucher disease. Proc
Natl Acad Sci USA 87, 1913-1916.
Baudard M, Flotte TR, Aran JM, Thierry AR, Pastan I, Pang
MG, Kearns WG, Gottesman MM (1996) Expression of the
human multidrug resistance and glucocerebrosidase cDNAs
from adeno-associated vectors: efficient promoter activity of
AAV sequences and in vivo delivery via liposomes. Hum
Gene Ther 7, 1309-1322.
Bauer G, Valdez P, Kearns K, Bahner I, Wen SF, Zaia JA, Kohn
DB (1997) Inhibition of human immunodeficiency virus-1
(HIV-1) replication after transduction of granulocyte colonystimulating
factor-mobilized CD34 + cells from HIV-1infected
donors using retroviral vectors containing anti-HIV-
1 genes. Blood 89, 2259-2267.
Beal PA and Dervan PB (1991) Second structural motif for
recognition of DNA by oligonucleotide-directed triple-helix
formation. Science 251, 1360-1363.
Beg AA, Sha WC, Bronson RT, Ghosh S, and Baltimore D
(1995) Embryonic lethality and liver degeneration in mice
lacking the RelA component of NF-κB. Nature 376, 167-
170.
Behr J-P (1994) Gene transfer with synthetic cationic
amphiphiles; prospects for gene therapy. Bioconjugate
Chem 5, 382-389.
Behr J-P, Demeneix B, Loeffler J-P, and Perez-Mutul J (1989)
Efficient gene transfer into mammalian primary endocrine
cells with lipopolyamine-coated DNA. Proc Natl Acad Sci
USA 86, 6982-6986.
Benn SI, Whitsitt JS, Broadley KN, Nanney LB, Perkins D, He
L, Patel M, Morgan JR, Swain WF, Davidson JM (1996)
Particle-mediated gene transfer with transforming growth
factor-β1 cDNAs enhances wound repair in rat skin. J Clin
Invest 98, 2894-2902.
Bennett MR, Anglin S, McEwan JR, Jagoe R, Newby AC, Evan
GI (1994) Inhibition of vascular smooth muscle cell
proliferation in vitro and in vivo by c-myc antisense
oligodeoxynucleotides. J Clin Invest 93, 820-828.